Prime Medicine (PRME) EBT Margin (2024 - 2026)
Prime Medicine's (PRME) quarterly EBT Margin came in at 26718.81% in Q1 2026, down 2315003.0% YoY from N/an in Q1 2025, and down 371.1% on a QoQ basis from 5671.6% in Q4 2025.
Powered by 
Analysis
Prime Medicine (PRME) EBT Margin (2024 - 2026) Analysis & Trends
Prime Medicine (PRME) has 3 years of EBT Margin data on file, last reported at 26718.81% in Q1 2026.
- Quarterly EBT Margin fell 2315003.0% year-over-year to 26718.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11235.37% (down 597939.0% YoY) and the FY2025 annual result came in at 4408.55%, up 215806.0% from the prior year.
- EBT Margin retreated to 26718.81% in Q1 2026, from 5671.6% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 1936.6% in Q4 2024 to a low of 26718.81% in Q1 2026.
- A 3-year average of 10702.04% and a median of 6695.95% in 2025 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2025 — EBT Margin jumped 1497288 bps — and 2026, when it slumped 2315003 bps.
- Tracing PRME's EBT Margin over 3 years: stood at 1936.6% in 2024, then plunged by 193 bps to 5671.6% in 2025, then tumbled by 371 bps to 26718.81% in 2026.
- The last three EBT Margin figures came in at 26718.81% (Q1 2026), 5671.6% (Q4 2025), and 10155.35% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | Prime Medicine | 653.96 Mn | 653.96 Mn | - | -3,682.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,682.58% |
| Mar 31, 2026 | -5,798.25% |
| Dec 31, 2025 | -5,671.24% |
| Sep 30, 2025 | -4,312.82% |
| Jun 30, 2025 | -4,716.68% |
| Mar 31, 2025 | -3,568.78% |
| Dec 31, 2024 | -1,936.60% |
| Sep 30, 2024 | -25,128.23% |
| Mar 31, 2024 | -7,720.30% |